Aaron Small’s Post

While researching how to increase blood flow and improve drug delivery to cancerous tumors, Dr. Rakesh Jain and his team of researchers stumbled upon a major discovery. While combining Bevacizumb and Losartan, the team discovered that this combination of drugs can also be used to improve the treatment of tuberculosis! Dr. Rakesh Jain, winner of the 2022 Szent-Györgyi Prize in cancer research, and his research lab receive funds from the National Foundation for Cancer Research. Although this advancement is not geared towards finding a cure for cancer, it is a major medical development that should be celebrated. You can find more information about the groundbreaking discovery here: https://lnkd.in/ef5w4qHQ #nfcr #makecurespossible #research #cancer #cancerresearch #funding #tb #tuberculosis #medical #advancement #medicaladvancement #changetheworld #makeadifference #nonprofit #donate #support #venture

News from Cancer Research UK: At-home saliva test could help diagnose prostate cancer sooner A spit test that predicts people's genetic risk of prostate cancer could help find more cases earlier, according to the BARCODE 1 trial. The post At-home saliva test could help diagnose prostate cancer sooner appeared first on Cancer Research UK - Cancer News. 👉🏽👉🏽 https://lnkd.in/e4eKSAMY #fundraising #relayforlife #cancerresearchuk #savinglives

July is Sarcoma and Bone Cancer Awareness Month, a time to raise awareness about these challenging cancers. Sarcomas are rare malignant cancers that develop in connective tissues and can spread to other body parts. Ways to contribute to raising awareness include educating yourself about signs, symptoms, and risk factors, participating in events, advocating for increased research funding, and donating to cancer organizations. #collaborativecancercare #sarcomacancer #bonecancer #cancerawareness

Did you know that advancements in women's health science have led to breakthroughs in breast cancer detection? From improved screening methods to targeted therapies, science is revolutionising how we diagnose and treat this disease. We recently had Breast Cancer Now as a partner at our event and talking about how their charity is devoted to researching breast cancer, did you go by their stand? #HealthcareSicenceWeek

03/03 World Triple-Negative Breast Cancer (TNBC) Day 🎗 TNBC is a subtype of breast cancer representing about 10-15% of all cases and tends to be more aggressive and have a poorer prognosis compared to other types of breast cancer. Early diagnosis and treatment are crucial due to its rapid progression. At Firalis Molecular Precision, we're committed to raising awareness of #TNBC and supporting efforts to find effective treatments. Our advanced platforms and scientific expertise in NGS, Spatial Transcriptomics, Single-cell Sequencing, and custom RT-qPCR, enable biopharmaceutical organizations, researchers, and #healthcare professionals to understand the complexities of TNBC and discover novel treatment strategies. By collaborating, leveraging cutting-edge technologies and relying on our experts know-how, we can accelerate the development of targeted therapies and improve outcomes for patients affected by this challenging disease. https://lnkd.in/e9W3beMq.

NM Genomix (Bulgaria) and OncoInv (the Netherlands) have joined forces to make multi cancer early detection available in Bulgaria. OncoSeek® is a patient-friendly product to detect cancer as it is on a blood sample and requires no biopsy or imaging equipment. Starting January 2024 NM Genomix will offer OncoSeek® in Bulgaria as a quicker and less painful means of screening for cancer.   The mission of OncoInv is to make multi-cancer early detection solutions available to as many people as possible, thus improving the outcome for patients and their families. OncoInv offers its products and services on a not-for-profit basis in Low- and Middle-Income countries to ensure high availability by minimizing the costs. OncoInv is a fully owned subsidiary of the non-profit foundation Inspire2Live.   Read more at https://lnkd.in/enFqqvsf   #oncoseek #multicancerearlydetection #bloodsample #cancer #earlydetection #screening

🌟 Empower research, by donating tumours. As you know, tumours hold valuable information that can help researchers unlock new treatments and therapies for salivary gland cancer patients. Does your patient know that they can donate theirs to the biobank at the Christie Hospital in Manchester? Help empower other clinicians in their study of this rare disease, ultimately leading to better outcomes for patients in time. Want to be a part of the solution? Don't hesitate to learn more about the biobank on our website. https://lnkd.in/egGsXH8W #BioBank #ChristieBiobank #DonateForACure #MedicalResearch #DonateYourTumour #TumourResearch #RareCancerResearch 

News from Cancer Research UK: CAFs and cross-talk – a recipe to close the gap on pancreatic cancer? A determined junior group leader thinks the key to tackling pancreatic cancer lay in the complexity of cancer associated fibroblasts… The post CAFs and cross-talk – a recipe to close the gap on pancreatic cancer? appeared first on Cancer Research UK - Cancer News. 👉🏽👉🏽 https://lnkd.in/eNZHdqVf #fundraising #relayforlife #cancerresearchuk #savinglives

Today is Stand Up to Cancer Day! 🎗️ Stand Up To Cancer (SU2C) funds and develops the newest and most promising cancer treatments to help patients today. SU2C dramatically accelerates the rate of new discoveries by connecting top scientists in unprecedented collaborations to create breakthroughs. SU2C innovations lead to better cancer prevention, diagnosis, and treatment, which means that we can help save lives now. If you're ready to help send cancer on its way, get involved! Donate to SU2C or one of the many other organizations fighting cancer today and every day. Learn more about the work we're doing and how you can make a difference: https://buff.ly/42dHuId #KissCancerGoodbye 💋

We need to find answers as to why the rates of bowel cancer diagnoses and deaths in younger people is on the rise. TOMORROW is our Annual Giving Day, with all donations MATCHED so they have DOUBLE the impact. $300 = $600 can help fund next-generation sequencing of a tumour to identify actionable genetic alterations that influence the diagnosis, prognosis, and tailored treatment of early-onset bowel cancer patients. Please save the date and help us reach our $200,000 target on 19 June to fund early-onset bowel cancer research and build a path toward a cure. #BowelCancerAustralia #Never2Young #RedAppleDay #AnnualGivingDay